It started in a hospital car park.

Dr. Amara Nwosu

CEO & Co-founder

MBBS, University of Nigeria Nsukka. Seven years as a medical officer in Abuja public health. Left the FMOH in 2023 after co-authoring a study showing that documentation burden was the top reason Nigerian doctors were leaving for the UK. She decided to fix the tool problem instead of writing another study about it. At Clinohour she leads product vision, clinical advisory, and NHIA regulatory relationships.

“Every extra hour a doctor spends on paperwork is an hour taken from a patient. That trade-off is visible and measurable. We built Clinohour to take that trade-off off the table.”

Ifeanyi Eze

CTO & Co-founder

BSc Computer Engineering, University of Lagos. Four years at Flutterwave (platform engineering), then two years building a telemedicine product. Deep experience in low-latency audio processing and healthcare API integrations. At Clinohour he owns architecture, AWS integration, and the clinical NLP pipeline.

“The hard part is not the AI. It is making the AI work on a 2G connection, on a two-year-old Android, in a room with background noise from a hospital ward. That is the actual product.”

Zainab Bello

CPO & Co-founder

MSc Human-Computer Interaction, Sheffield Hallam University. Returned to Abuja in 2022 after leading UX at a Kano-based health startup, with years of clinical workflow design and user research with frontline health workers. At Clinohour she leads product design, clinical workflow UX, user research, and customer success.

“Doctors are not going to learn new software. The tool has to fit into how they already work — not the other way around. Every workflow decision in Clinohour started with that constraint.”

Dr. Nomvula Dlamini

Chief Clinical Officer

MBChB, University of Cape Town. PhD in Global Health (infectious disease), Johns Hopkins Bloomberg School of Public Health. Six years at WHO AFRO in Brazzaville. A South African national, she joined Clinohour as a formal clinical partner in September 2024 and leads clinical content standards, differential diagnosis model validation, and regulatory submissions.

“A differential that ignores where the patient lives is not clinical judgement, it is memorised trivia. Local prevalence is the starting point of safe medicine.”

01

Clinical accuracy is non-negotiable

We do not guess. When Clinohour’s confidence in a differential is low, it says so and tells the clinician why.

02

West African medicine is the baseline

Our disease prevalence weights and drug formulary reflect what Nigerian clinicians actually see — not a localisation afterthought on Western textbook distributions.

03

The product works where patients are

Offline-first audio capture, graceful degradation on poor connections, and a UI that functions on a budget Android.